
Blood Banking and Blood Products Industry Research Report 2025
Description
Summary
According to APO Research, The global Blood Banking and Blood Products market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Blood Banking and Blood Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Blood Banking and Blood Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Blood Banking and Blood Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Blood Banking and Blood Products include Red Cross Society of China, Yuanda Shuyang, Weiguang Bio, Tiantan Bio, CBPO, Shuanglin Bio, RAAS, Nanyue Bio and Hualan Bio, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Blood Banking and Blood Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Banking and Blood Products.
The Blood Banking and Blood Products market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Blood Banking and Blood Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Blood Banking and Blood Products Segment by Company
Red Cross Society of China
Yuanda Shuyang
Weiguang Bio
Tiantan Bio
CBPO
Shuanglin Bio
RAAS
Nanyue Bio
Hualan Bio
Boya Bio
Vitalant
Takeda
Sanquin Blood Supply Foundation
Octapharma
NHS Blood and Transplant
New York Blood Center
National Blood Transfusion Council
LFB Group
KM Biologics
Kedrion
Japan Red Cross Society
Grifols
CSL
Canadian Blood Services
BPL
Blood Bank of Alaska
Biotest
Australia Red Cross
American Red Cross
America’s Blood Centers
Blood Banking and Blood Products Segment by Type
RBCs
Whole Blood
Plasma
Plasma Fractionation Products
Plts
Blood Banking and Blood Products Segment by Application
Clinic
Hospital
Retail Pharmacy
Others
Blood Banking and Blood Products Segment by Application
Clinic
Hospital
Retail Pharmacy
Others
Blood Banking and Blood Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Banking and Blood Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blood Banking and Blood Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Banking and Blood Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Blood Banking and Blood Products companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, The global Blood Banking and Blood Products market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Blood Banking and Blood Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Blood Banking and Blood Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Blood Banking and Blood Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Blood Banking and Blood Products include Red Cross Society of China, Yuanda Shuyang, Weiguang Bio, Tiantan Bio, CBPO, Shuanglin Bio, RAAS, Nanyue Bio and Hualan Bio, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Blood Banking and Blood Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Banking and Blood Products.
The Blood Banking and Blood Products market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Blood Banking and Blood Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Blood Banking and Blood Products Segment by Company
Red Cross Society of China
Yuanda Shuyang
Weiguang Bio
Tiantan Bio
CBPO
Shuanglin Bio
RAAS
Nanyue Bio
Hualan Bio
Boya Bio
Vitalant
Takeda
Sanquin Blood Supply Foundation
Octapharma
NHS Blood and Transplant
New York Blood Center
National Blood Transfusion Council
LFB Group
KM Biologics
Kedrion
Japan Red Cross Society
Grifols
CSL
Canadian Blood Services
BPL
Blood Bank of Alaska
Biotest
Australia Red Cross
American Red Cross
America’s Blood Centers
Blood Banking and Blood Products Segment by Type
RBCs
Whole Blood
Plasma
Plasma Fractionation Products
Plts
Blood Banking and Blood Products Segment by Application
Clinic
Hospital
Retail Pharmacy
Others
Blood Banking and Blood Products Segment by Application
Clinic
Hospital
Retail Pharmacy
Others
Blood Banking and Blood Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Banking and Blood Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blood Banking and Blood Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Banking and Blood Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Blood Banking and Blood Products companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
141 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Blood Banking and Blood Products by Type
- 2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
- 2.2.2 RBCs
- 2.2.3 Whole Blood
- 2.2.4 Plasma
- 2.2.5 Plasma Fractionation Products
- 2.2.6 Plts
- 2.3 Blood Banking and Blood Products by Application
- 2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
- 2.3.2 Clinic
- 2.3.3 Hospital
- 2.3.4 Retail Pharmacy
- 2.3.5 Others
- 2.4 Assumptions and Limitations
- 3 Blood Banking and Blood Products Breakdown Data by Type
- 3.1 Global Blood Banking and Blood Products Historic Market Size by Type (2020-2025)
- 3.2 Global Blood Banking and Blood Products Forecasted Market Size by Type (2026-2031)
- 4 Blood Banking and Blood Products Breakdown Data by Application
- 4.1 Global Blood Banking and Blood Products Historic Market Size by Application (2020-2025)
- 4.2 Global Blood Banking and Blood Products Forecasted Market Size by Application (2026-2031)
- 5 Global Growth Trends
- 5.1 Global Blood Banking and Blood Products Market Perspective (2020-2031)
- 5.2 Global Blood Banking and Blood Products Growth Trends by Region
- 5.2.1 Global Blood Banking and Blood Products Market Size by Region: 2020 VS 2024 VS 2031
- 5.2.2 Blood Banking and Blood Products Historic Market Size by Region (2020-2025)
- 5.2.3 Blood Banking and Blood Products Forecasted Market Size by Region (2026-2031)
- 5.3 Blood Banking and Blood Products Market Dynamics
- 5.3.1 Blood Banking and Blood Products Industry Trends
- 5.3.2 Blood Banking and Blood Products Market Drivers
- 5.3.3 Blood Banking and Blood Products Market Challenges
- 5.3.4 Blood Banking and Blood Products Market Restraints
- 6 Market Competitive Landscape by Players
- 6.1 Global Top Blood Banking and Blood Products Players by Revenue
- 6.1.1 Global Top Blood Banking and Blood Products Players by Revenue (2020-2025)
- 6.1.2 Global Blood Banking and Blood Products Revenue Market Share by Players (2020-2025)
- 6.2 Global Blood Banking and Blood Products Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Blood Banking and Blood Products Head Office and Area Served
- 6.4 Global Blood Banking and Blood Products Players, Product Type & Application
- 6.5 Global Blood Banking and Blood Products Manufacturers Established Date
- 6.6 Global Blood Banking and Blood Products Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
- 7 North America
- 7.1 North America Blood Banking and Blood Products Market Size (2020-2031)
- 7.2 North America Blood Banking and Blood Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 7.3 North America Blood Banking and Blood Products Market Size by Country (2020-2025)
- 7.4 North America Blood Banking and Blood Products Market Size by Country (2026-2031)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
- 8 Europe
- 8.1 Europe Blood Banking and Blood Products Market Size (2020-2031)
- 8.2 Europe Blood Banking and Blood Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 8.3 Europe Blood Banking and Blood Products Market Size by Country (2020-2025)
- 8.4 Europe Blood Banking and Blood Products Market Size by Country (2026-2031)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
- 9 Asia-Pacific
- 9.1 Asia-Pacific Blood Banking and Blood Products Market Size (2020-2031)
- 9.2 Asia-Pacific Blood Banking and Blood Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 9.3 Asia-Pacific Blood Banking and Blood Products Market Size by Country (2020-2025)
- 9.4 Asia-Pacific Blood Banking and Blood Products Market Size by Country (2026-2031)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
- 10 South America
- 10.1 South America Blood Banking and Blood Products Market Size (2020-2031)
- 10.2 South America Blood Banking and Blood Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 10.3 South America Blood Banking and Blood Products Market Size by Country (2020-2025)
- 10.4 South America Blood Banking and Blood Products Market Size by Country (2026-2031)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
- 11 Middle East & Africa
- 11.1 Middle East & Africa Blood Banking and Blood Products Market Size (2020-2031)
- 11.2 Middle East & Africa Blood Banking and Blood Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 11.3 Middle East & Africa Blood Banking and Blood Products Market Size by Country (2020-2025)
- 11.4 Middle East & Africa Blood Banking and Blood Products Market Size by Country (2026-2031)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
- 12 Players Profiled
- 12.1 Red Cross Society of China
- 12.1.1 Red Cross Society of China Company Information
- 12.1.2 Red Cross Society of China Business Overview
- 12.1.3 Red Cross Society of China Revenue in Blood Banking and Blood Products Business (2020-2025)
- 12.1.4 Red Cross Society of China Blood Banking and Blood Products Product Portfolio
- 12.1.5 Red Cross Society of China Recent Developments
- 12.2 Yuanda Shuyang
- 12.2.1 Yuanda Shuyang Company Information
- 12.2.2 Yuanda Shuyang Business Overview
- 12.2.3 Yuanda Shuyang Revenue in Blood Banking and Blood Products Business (2020-2025)
- 12.2.4 Yuanda Shuyang Blood Banking and Blood Products Product Portfolio
- 12.2.5 Yuanda Shuyang Recent Developments
- 12.3 Weiguang Bio
- 12.3.1 Weiguang Bio Company Information
- 12.3.2 Weiguang Bio Business Overview
- 12.3.3 Weiguang Bio Revenue in Blood Banking and Blood Products Business (2020-2025)
- 12.3.4 Weiguang Bio Blood Banking and Blood Products Product Portfolio
- 12.3.5 Weiguang Bio Recent Developments
- 12.4 Tiantan Bio
- 12.4.1 Tiantan Bio Company Information
- 12.4.2 Tiantan Bio Business Overview
- 12.4.3 Tiantan Bio Revenue in Blood Banking and Blood Products Business (2020-2025)
- 12.4.4 Tiantan Bio Blood Banking and Blood Products Product Portfolio
- 12.4.5 Tiantan Bio Recent Developments
- 12.5 CBPO
- 12.5.1 CBPO Company Information
- 12.5.2 CBPO Business Overview
- 12.5.3 CBPO Revenue in Blood Banking and Blood Products Business (2020-2025)
- 12.5.4 CBPO Blood Banking and Blood Products Product Portfolio
- 12.5.5 CBPO Recent Developments
- 12.6 Shuanglin Bio
- 12.6.1 Shuanglin Bio Company Information
- 12.6.2 Shuanglin Bio Business Overview
- 12.6.3 Shuanglin Bio Revenue in Blood Banking and Blood Products Business (2020-2025)
- 12.6.4 Shuanglin Bio Blood Banking and Blood Products Product Portfolio
- 12.6.5 Shuanglin Bio Recent Developments
- 12.7 RAAS
- 12.7.1 RAAS Company Information
- 12.7.2 RAAS Business Overview
- 12.7.3 RAAS Revenue in Blood Banking and Blood Products Business (2020-2025)
- 12.7.4 RAAS Blood Banking and Blood Products Product Portfolio
- 12.7.5 RAAS Recent Developments
- 12.8 Nanyue Bio
- 12.8.1 Nanyue Bio Company Information
- 12.8.2 Nanyue Bio Business Overview
- 12.8.3 Nanyue Bio Revenue in Blood Banking and Blood Products Business (2020-2025)
- 12.8.4 Nanyue Bio Blood Banking and Blood Products Product Portfolio
- 12.8.5 Nanyue Bio Recent Developments
- 12.9 Hualan Bio
- 12.9.1 Hualan Bio Company Information
- 12.9.2 Hualan Bio Business Overview
- 12.9.3 Hualan Bio Revenue in Blood Banking and Blood Products Business (2020-2025)
- 12.9.4 Hualan Bio Blood Banking and Blood Products Product Portfolio
- 12.9.5 Hualan Bio Recent Developments
- 12.10 Boya Bio
- 12.10.1 Boya Bio Company Information
- 12.10.2 Boya Bio Business Overview
- 12.10.3 Boya Bio Revenue in Blood Banking and Blood Products Business (2020-2025)
- 12.10.4 Boya Bio Blood Banking and Blood Products Product Portfolio
- 12.10.5 Boya Bio Recent Developments
- 12.11 Vitalant
- 12.11.1 Vitalant Company Information
- 12.11.2 Vitalant Business Overview
- 12.11.3 Vitalant Revenue in Blood Banking and Blood Products Business (2020-2025)
- 12.11.4 Vitalant Blood Banking and Blood Products Product Portfolio
- 12.11.5 Vitalant Recent Developments
- 12.12 Takeda
- 12.12.1 Takeda Company Information
- 12.12.2 Takeda Business Overview
- 12.12.3 Takeda Revenue in Blood Banking and Blood Products Business (2020-2025)
- 12.12.4 Takeda Blood Banking and Blood Products Product Portfolio
- 12.12.5 Takeda Recent Developments
- 12.13 Sanquin Blood Supply Foundation
- 12.13.1 Sanquin Blood Supply Foundation Company Information
- 12.13.2 Sanquin Blood Supply Foundation Business Overview
- 12.13.3 Sanquin Blood Supply Foundation Revenue in Blood Banking and Blood Products Business (2020-2025)
- 12.13.4 Sanquin Blood Supply Foundation Blood Banking and Blood Products Product Portfolio
- 12.13.5 Sanquin Blood Supply Foundation Recent Developments
- 12.14 Octapharma
- 12.14.1 Octapharma Company Information
- 12.14.2 Octapharma Business Overview
- 12.14.3 Octapharma Revenue in Blood Banking and Blood Products Business (2020-2025)
- 12.14.4 Octapharma Blood Banking and Blood Products Product Portfolio
- 12.14.5 Octapharma Recent Developments
- 12.15 NHS Blood and Transplant
- 12.15.1 NHS Blood and Transplant Company Information
- 12.15.2 NHS Blood and Transplant Business Overview
- 12.15.3 NHS Blood and Transplant Revenue in Blood Banking and Blood Products Business (2020-2025)
- 12.15.4 NHS Blood and Transplant Blood Banking and Blood Products Product Portfolio
- 12.15.5 NHS Blood and Transplant Recent Developments
- 12.16 New York Blood Center
- 12.16.1 New York Blood Center Company Information
- 12.16.2 New York Blood Center Business Overview
- 12.16.3 New York Blood Center Revenue in Blood Banking and Blood Products Business (2020-2025)
- 12.16.4 New York Blood Center Blood Banking and Blood Products Product Portfolio
- 12.16.5 New York Blood Center Recent Developments
- 12.17 National Blood Transfusion Council
- 12.17.1 National Blood Transfusion Council Company Information
- 12.17.2 National Blood Transfusion Council Business Overview
- 12.17.3 National Blood Transfusion Council Revenue in Blood Banking and Blood Products Business (2020-2025)
- 12.17.4 National Blood Transfusion Council Blood Banking and Blood Products Product Portfolio
- 12.17.5 National Blood Transfusion Council Recent Developments
- 12.18 LFB Group
- 12.18.1 LFB Group Company Information
- 12.18.2 LFB Group Business Overview
- 12.18.3 LFB Group Revenue in Blood Banking and Blood Products Business (2020-2025)
- 12.18.4 LFB Group Blood Banking and Blood Products Product Portfolio
- 12.18.5 LFB Group Recent Developments
- 12.19 KM Biologics
- 12.19.1 KM Biologics Company Information
- 12.19.2 KM Biologics Business Overview
- 12.19.3 KM Biologics Revenue in Blood Banking and Blood Products Business (2020-2025)
- 12.19.4 KM Biologics Blood Banking and Blood Products Product Portfolio
- 12.19.5 KM Biologics Recent Developments
- 12.20 Kedrion
- 12.20.1 Kedrion Company Information
- 12.20.2 Kedrion Business Overview
- 12.20.3 Kedrion Revenue in Blood Banking and Blood Products Business (2020-2025)
- 12.20.4 Kedrion Blood Banking and Blood Products Product Portfolio
- 12.20.5 Kedrion Recent Developments
- 12.21 Japan Red Cross Society
- 12.21.1 Japan Red Cross Society Company Information
- 12.21.2 Japan Red Cross Society Business Overview
- 12.21.3 Japan Red Cross Society Revenue in Blood Banking and Blood Products Business (2020-2025)
- 12.21.4 Japan Red Cross Society Blood Banking and Blood Products Product Portfolio
- 12.21.5 Japan Red Cross Society Recent Developments
- 12.22 Grifols
- 12.22.1 Grifols Company Information
- 12.22.2 Grifols Business Overview
- 12.22.3 Grifols Revenue in Blood Banking and Blood Products Business (2020-2025)
- 12.22.4 Grifols Blood Banking and Blood Products Product Portfolio
- 12.22.5 Grifols Recent Developments
- 12.23 CSL
- 12.23.1 CSL Company Information
- 12.23.2 CSL Business Overview
- 12.23.3 CSL Revenue in Blood Banking and Blood Products Business (2020-2025)
- 12.23.4 CSL Blood Banking and Blood Products Product Portfolio
- 12.23.5 CSL Recent Developments
- 12.24 Canadian Blood Services
- 12.24.1 Canadian Blood Services Company Information
- 12.24.2 Canadian Blood Services Business Overview
- 12.24.3 Canadian Blood Services Revenue in Blood Banking and Blood Products Business (2020-2025)
- 12.24.4 Canadian Blood Services Blood Banking and Blood Products Product Portfolio
- 12.24.5 Canadian Blood Services Recent Developments
- 12.25 BPL
- 12.25.1 BPL Company Information
- 12.25.2 BPL Business Overview
- 12.25.3 BPL Revenue in Blood Banking and Blood Products Business (2020-2025)
- 12.25.4 BPL Blood Banking and Blood Products Product Portfolio
- 12.25.5 BPL Recent Developments
- 12.26 Blood Bank of Alaska
- 12.26.1 Blood Bank of Alaska Company Information
- 12.26.2 Blood Bank of Alaska Business Overview
- 12.26.3 Blood Bank of Alaska Revenue in Blood Banking and Blood Products Business (2020-2025)
- 12.26.4 Blood Bank of Alaska Blood Banking and Blood Products Product Portfolio
- 12.26.5 Blood Bank of Alaska Recent Developments
- 12.27 Biotest
- 12.27.1 Biotest Company Information
- 12.27.2 Biotest Business Overview
- 12.27.3 Biotest Revenue in Blood Banking and Blood Products Business (2020-2025)
- 12.27.4 Biotest Blood Banking and Blood Products Product Portfolio
- 12.27.5 Biotest Recent Developments
- 12.28 Australia Red Cross
- 12.28.1 Australia Red Cross Company Information
- 12.28.2 Australia Red Cross Business Overview
- 12.28.3 Australia Red Cross Revenue in Blood Banking and Blood Products Business (2020-2025)
- 12.28.4 Australia Red Cross Blood Banking and Blood Products Product Portfolio
- 12.28.5 Australia Red Cross Recent Developments
- 12.29 American Red Cross
- 12.29.1 American Red Cross Company Information
- 12.29.2 American Red Cross Business Overview
- 12.29.3 American Red Cross Revenue in Blood Banking and Blood Products Business (2020-2025)
- 12.29.4 American Red Cross Blood Banking and Blood Products Product Portfolio
- 12.29.5 American Red Cross Recent Developments
- 12.30 America’s Blood Centers
- 12.30.1 America’s Blood Centers Company Information
- 12.30.2 America’s Blood Centers Business Overview
- 12.30.3 America’s Blood Centers Revenue in Blood Banking and Blood Products Business (2020-2025)
- 12.30.4 America’s Blood Centers Blood Banking and Blood Products Product Portfolio
- 12.30.5 America’s Blood Centers Recent Developments
- 13 Report Conclusion
- 14 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.